Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
341.00
+8.00 (2.40%)
Aug 6, 2026, 3:30 PM JST

Kringle Pharma Cash Flow Statement

Millions JPY. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-918-914-754-852-330-299
Other Operating Activities
13213015514734184
Change in Accounts Receivable
--7-7699
Change in Inventory
-4469-14-34-268
Change in Accounts Payable
-20-16-13511821-41
Change in Other Net Operating Assets
2851-3-8111-135
Operating Cash Flow
-520-755-661-68915-560
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Investment in Securities
--131-121-120-254-
Other Investing Activities
1-23----
Investing Cash Flow
-1-154-121-120-254-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Issuance of Common Stock
2238483869603612
Other Financing Activities
------17
Financing Cash Flow
2238483869603595

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Miscellaneous Cash Flow Adjustments
1--1---1
Net Cash Flow
-297-82555-74036434

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Levered Free Cash Flow
-312.63-581.13-552.63-538.63-185.25-505.75
Unlevered Free Cash Flow
-312.63-581.13-552.63-538.63-185.25-505.75

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Income Tax Paid
1111-61
Change in Working Capital
26529-62164-345